أعرض في EDS

Supplementary Table 2. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

التفاصيل البيبلوغرافية
العنوان:	Supplementary Table 2. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
المؤلفون:	Wayne L. Furman, Alberto S. Pappo, Victor M. Santana, Rachel C. Brennan, Shenghua Mao, Jianrong Wu, William E. Janssen, Wing Leung, Catherine Y. Ng, Aaron Shafer, Michael Meagher, Paul Hutson, Jacquelyn A. Hank, Paul M. Sondel, Barry L. Shulkin, M. Beth McCarville, Sara M. Federico
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	Human anti-human antibody (HAHA) level and peak hu14.18K322A serum level by course and prior antibody therapy.
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120d7121dd373ab23a3e06c8088d7313Test https://doi.org/10.1158/1078-0432.22468163Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....120d7121dd373ab23a3e06c8088d7313
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.